abstract |
The present invention relates to novel indol-3-yl-carbonyl-azaspiropiperidine derivatives as V1a receptor antagonists, methods for their preparation, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful for the prevention and / or treatment of anxiety and depressive disorders and other diseases. In particular, the invention relates to compounds of formula (I)n n n Formula In n n n n n n n Wheren n n R 1 to R 6 , U, V, W, X, Y and Z are as defined herein |